MID-VOLUME · HOSP-HEAVY
gemfibrozil Side Effects
gemfibrozil (also sold as Lopid) sits MID-VOLUME #273 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 35.4% mention hospitalization (5,298 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 14,954
- FAERS reports
FDA Adverse Event Reporting System extract for gemfibrozil. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
gemfibrozil: 35.4% mention hospitalization (5,298 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #273 of 524 by FAERS report count.
Mid-book FAERS page for gemfibrozil (Lopid) (14,954 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
NAUSEA leads 883 of 14,954 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (4,405 reports)
Reporting taper since 2004 peak
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,208 reports, 8.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 369 |
| COMPLETED SUICIDE | 112 |
| RENAL FAILURE | 103 |
| PNEUMONIA | 99 |
| MYOCARDIAL INFARCTION | 89 |
| CARDIAC ARREST | 79 |
| SEPSIS | 75 |
| ASTHENIA | 66 |
| DYSPNOEA | 65 |
| CARDIO-RESPIRATORY ARREST | 63 |
| NAUSEA | 63 |
| VOMITING | 59 |
| PAIN | 58 |
| ANXIETY | 57 |
| CARDIAC FAILURE CONGESTIVE | 57 |
| CHRONIC KIDNEY DISEASE | 56 |
| DRUG INTERACTION | 54 |
| ACUTE KIDNEY INJURY | 53 |
| INJURY | 51 |
| RHABDOMYOLYSIS | 50 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (5,298, 35.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| RHABDOMYOLYSIS | 466 |
| NAUSEA | 381 |
| MYOCARDIAL INFARCTION | 327 |
| ASTHENIA | 321 |
| RENAL FAILURE ACUTE | 317 |
| DYSPNOEA | 309 |
| PNEUMONIA | 299 |
| DIARRHOEA | 281 |
| VOMITING | 279 |
| FALL | 276 |
| FATIGUE | 276 |
| RENAL FAILURE | 276 |
| CARDIAC FAILURE CONGESTIVE | 271 |
| PAIN | 263 |
| DIZZINESS | 254 |
| DRUG INTERACTION | 245 |
| CHEST PAIN | 243 |
| ANAEMIA | 222 |
| WEIGHT DECREASED | 204 |
| CEREBROVASCULAR ACCIDENT | 203 |
How to read gemfibrozil FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 14,954 voluntary reports linked to gemfibrozil (Lopid), 2004-2025. Death is listed on 1,208 (8.1%). Hospitalization appears on 5,298 (35.4%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 35.4% mention hospitalization (5,298 reports).
Read with gemfibrozil
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 14,997 FAERS cases (Δ 43 heavier vs gemfibrozil); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 14,896 FAERS cases (Δ 58 lighter vs gemfibrozil); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 15,113 FAERS cases (Δ 159 heavier vs gemfibrozil); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 14,664 FAERS cases (Δ 290 lighter vs gemfibrozil); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 54.0 pp vs gemfibrozil's DEATH-HEAVY): CASELOAD · HOSP-MID.
gemfibrozil stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.